Home LiteratureArticle Details
PMID: 805205 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Specificity of human lymphocyte complement receptors.

The Journal of experimental medicine ·Vol. 141 ·No. 5 ·1975-05-01 ·Pages 1163-80

Ross GD, Polley MJ

Abstract

Erythrocytes, bone marrow-derived lymphocytes, monocytes, and granulocytes were shown to have a receptor activity for C4. Theis C4 receptor activity was studied in relation to the previously identified C3b and C3d receptors. By assay for inhibition of rosette formation by fluid-phase complement (C), only two different lymphocyte C receptors were demonstrated. The immune adherence receptor, the only one of the two shared in common with erythrocytes, was specific for C4 or the C3c region of C3b, but was unreactive with C3d. The other lymphocyte receptor, the C3d receptor, was specific for C3d fragments, but would also react to a lesser extent with the C3d region of uncleaved C3b. ThC3d receptor did not react with either C3c or C4. This specificity of the C3d receptor allowed certain cells which contained only C3d receptors to form rosettes with EAC1-3b and EAC1-3d, but not with EAC14. However, because C3d receptors bound EAC1-3d or C3d fragments more firmly than they did EAC1-3b or C3b fragments, many other types of cells containing only C3d receptors, formed rosettes with EAC1-3d but not with EAC1-3b. Erythrocytes and those lymphocytes which contained only immune adherence receptors, formed rosettes with EAC14 and EAC1-3D but not with EAC1-3d. A double-label assay was devised for the simultaneous detection of both types of C receptors on individual lymphocytes. This assay involved fluorescence labeling of one of the two C receptors with soluble C fragments in combination with the usual rosette method for labeling the other type of C receptor. With this double-label assay, it was observed that the two different lymphocyte C receptors capped independently and thus were located on different molecules which could each move through the fluid membrane matrix independently of the other.

MeSH Terms
Animals Antilymphocyte Serum B-Lymphocytes/immunology Binding Sites Calcium Cell Line Complement System Proteins Erythrocytes/immunology Fluorescent Antibody Technique Granulocytes/immunology Humans Immune Sera Immunoglobulin M Immunoglobulins Leukemia, Lymphoid/immunology Lymphoid Tissue Monocytes/immunology Palatine Tonsil/cytology,immunology Phagocytosis Protein Binding Sheep/immunology Waldenstrom Macroglobulinemia/immunology
Chemicals
Antilymphocyte Serum Immune Sera Immunoglobulin M Immunoglobulins Complement System Proteins Calcium
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Ross G D
Polley M J
References (25)
25 references, click to expand
  1. Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum.
    J Exp Med. 1969 May 1;129(5):1109-30 PMID: 5778786
  2. The second component of human complement: its isolation, fragmentation by C'1 esterase, and incorporation into C'3 convertase.
    J Exp Med. 1968 Sep 1;128(3):533-51 PMID: 5666963
  3. Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3.
    Exp Cell Res. 1968 Jul;51(1):45-67 PMID: 5661952
  4. The demonstration in human serum of "conglutinogen-activating factor" and its effect on the third component of complement.
    J Immunol. 1968 Apr;100(4):691-8 PMID: 5645214
  5. Physico-chemical characteristics of the third and fourth component of complement after dissociation from complement-cell complexes.
    Immunology. 1967 Sep;13(3):293-305 PMID: 6054730
  6. Hemolytic activity of lipoprotein-depleted serum and the effect of certain anions on complement.
    J Immunol. 1966 Nov;97(5):680-5 PMID: 5926456
  7. A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE.
    J Clin Pathol. 1965 May;18:261-73 PMID: 14304234
  8. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.
    J Exp Med. 1965 Aug 1;122:277-98 PMID: 14316946
  9. COMPONENTS OF GUINEA PIG COMPLEMENT. I. SEPARATION OF A SERUM FRACTION ESSENTIAL FOR IMMUNE HEMOLYSIS AND IMMUNE ADHERENCE.
    J Exp Med. 1963 Nov 1;118:767-93 PMID: 14087621
  10. ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.
    J Exp Med. 1963 Sep 1;118:447-66 PMID: 14078003
  11. C3b inactivator of man. II. Fragments produced by C3b inactivator cleavage of cell-bound or fluid phase C3b.
    J Immunol. 1971 Sep;107(3):742-50 PMID: 4999095
  12. Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.
    J Exp Med. 1974 Oct 1;140(4):877-94 PMID: 4139225
  13. Conglutinin and immunoconglutinins.
    Adv Immunol. 1967;6:479-527 PMID: 4860249
  14. Receptor for soluble C3 and C3b on human lymphoblastoid (RAJI) cells. Properties and biologocal significance.
    J Exp Med. 1974 Mar 1;139(3):696-711 PMID: 4591176
  15. Cultured lymphoid cell lines from normal subjects: membrane associated immunoglobulins studied by the mixed antiglobulin reaction.
    Cell Immunol. 1972 Nov;5(3):446-58 PMID: 4118947
  16. A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization.
    J Exp Med. 1970 Oct 1;132(4):702-20 PMID: 4101362
  17. Receptor sites of human monocytes for IgG.
    Int Arch Allergy Appl Immunol. 1968;34(1):18-31 PMID: 4174441
  18. Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes.
    Blood. 1973 Dec;42(6):939-46 PMID: 4357270
  19. C3b inactivator of man. 3. Further purification and production of antibody to C3b INA.
    J Immunol. 1972 Mar;108(3):657-64 PMID: 4622188
  20. Combined studies of complement receptor and surface immunoglobulin-bearing cells and sheep erythrocyte rosette-forming cells in normal and leukemic human lymphocytes.
    J Clin Invest. 1973 Feb;52(2):377-85 PMID: 4567307
  21. Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.
    J Natl Cancer Inst. 1972 Sep;49(3):891-5 PMID: 4567231
  22. Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b.
    J Exp Med. 1973 Oct 1;138(4):798-811 PMID: 4542735
  23. Receptor for the fourth component of complement on human B lymphocytes and cultured human lymphoblastoid cells.
    J Exp Med. 1974 Nov 1;140(5):1336-47 PMID: 4547573
  24. Enharncement of the hemolytic activity of the second component of human complement by oxidation.
    J Exp Med. 1967 Dec 1;126(6):1013-25 PMID: 4964564
  25. Immune adherence by the fourth component of complement.
    Science. 1969 Jul 25;165(3891):396-8 PMID: 5815256
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1975-05-01
Pages
1163-80
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2189795
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com